Evidence map›Paper›PMID 37850115›Full record

ArticleBiotechnologia2023

Formation, characterization, and analysis of curcumin nanoformulation for evaluating its

Nilam Parmar, Abdulkhalik Mansuri, Krupali Trivedi, Khairah Ansari, Priyesh Kumar, Mohammed Azim Bagban, Devendrasinh Jhala, Alpesh Patel, Shiva Shankaran Chettiar

Open access · diamondAbstract read
In one paragraph

Article in Biotechnologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 11 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Nilam ParmarDepartment of Life Sciences, School of Sciences, Gujarat University, Ahmedabad, India.
Abdulkhalik MansuriDepartment of Biological and Life Sciences, School of Arts and Sciences, Ahmedabad University, Ahmedabad, India.
Krupali TrivediCell and Molecular Biology Laboratory, Department of Zoology, School of Sciences, Gujarat University, Ahmedabad, India.
Khairah AnsariCell and Molecular Biology Laboratory, Department of Zoology, School of Sciences, Gujarat University, Ahmedabad, India.
Priyesh KumarCell and Molecular Biology Laboratory, Department of Zoology, School of Sciences, Gujarat University, Ahmedabad, India.
Mohammed Azim BagbanDepartment of Microbiology, C.U. Shah Institute of Science, Gujarat University, Ahmedabad, Gujarat, India.
Devendrasinh JhalaCell and Molecular Biology Laboratory, Department of Zoology, School of Sciences, Gujarat University, Ahmedabad, India.
Alpesh PatelGenexplore Diagnostics and Research Centre Pvt. Ltd., Ahmedabad, Gujarat, India.
Shiva Shankaran ChettiarGenexplore Diagnostics and Research Centre Pvt. Ltd., Ahmedabad, Gujarat, India.
Gujarat University · INGenePath Dx (India) · INAhmedabad University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology holds significance in all fields of research, and the formation and surface alterations of nanomaterials are particularly important in this discipline. Nanoformulations synthesized with bioactive plant components play a crucial role in the improvement of several therapeutics and diagnostics. In the present study, we reported the synthesis of a curcumin nanoformulation (CN) by using curcumin and D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). The synthesized CN was characterized using dynamic light scattering, UV-Visible spectrophotometry, Fourier-transform infrared spectroscopy, field-emission scanning electron microscopy, and X-ray diffraction. Furthermore, it was evaluated for solubility, drug loading, encapsulation efficiency, stability,

Indexed as

anticancercurcumin nanoformulationD-α-tocopheryl polyethylene glycol 1000 succinatesolubilitystability

Identifiers

PMID37850115
PMCPMC10578130
OpenAlexW4387021948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.